Numerous parameters are measured for patients in the intensive care unit. The AI-based software from x-cardiac GmbH uses this data to calculate whether serious complications will occur. The doctors can then intervene before damage occurs. After…
The start-up Formo is a food biotech company that uses biotechnological processes to develop proteins for the food of the future. We spoke to Sandra Wilde, Formo’s Head of Food Science, about the current development status of the company and their…
BERLIN, GERMANY, August 04th, 2022 - Myelo Therapeutics GmbH, as a member of a pan-European consortium of research and industry partners, has successfully entered into the grant agreement negotiation phase potentially providing up to 17 million Euro…
A CRISPR-based rapid test called CrisprZyme could help general practitioners to diagnose heart attacks and distinguish between different types of prostate cancer. They do not even need a lab, as an international team of scientists – including Michael…
A large number of people are currently contracting COVID-19. Fortunately, most of them are experiencing only mild symptoms, largely thanks to the high vaccination rate. However, in some individuals the disease takes a much more severe cause and our…
Interview with: Prof. Jens Kurreck, TU Berlin and Director of the 3R Center Berlin
Cardiomyopathy is not a uniform disease. Rather, individual genetic defects lead to heart failure in different ways, an international consortium reports in “Science”. MDC researcher Norbert Hübner is one of the senior authors.
BERLIN, GERMANY, August 04, 2022 – Myelo Therapeutics GmbH, an Affiliate of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, SDAX) and member of a pan-European consortium of research and industry partners, was selected to…
An international consortium brings together 7,200 segments of the human genome that are virtually unexplored and presents a roadmap for integrating them into genome databases in “Nature Biotechnology”. They could hold information about what sets…
SCIENION’s UK operations to become global hub for contract manufacturing services
